Other Trials # Other interesting and active GLP analog trials include: Parkinsons Disease (NCT03659682) Alcohol-related Liver Disease (NCT06409130) Acute Ischemic Stroke (NCT05630586) Polycystic Ovary Syndrome (NCT05646199, NCT05702905, and more) For a literature review and deeper dive on this topic focused on research, see From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists 7
Success Rates For Reducing Alcohol Use Naltrexone Many studies have shown that naltrexone is effective at increasing the days of abstinence and reducing heavy-drinking days by 80.6% and 66.2% respectively
Like semaglutide, liraglutide is indicated as an adjunct to diet and physical activity
Redox Rep 27(1):4552 Simmonds SJ, Cuijpers I, Heymans S, Jones EAV (2020) Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding
The lack of Vitamin B12 in the diets of vegetarians has challenged researchers to develop veganic and vitamin-enriched dietary resources and supplements
These developments underscore the need for safer alternatives and enhanced vigilance, shaping future market dynamics